Related Experiment Video
Updated: Feb 19, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Biotin Thiamin Responsive Basal Ganglia Disease in Siblings
Vykuntaraju K Gowda1, Varunvenkat M Srinivasan2, Maya Bhat3
1Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Associate Prof of Pediatric Neurology, Bangalore, Karnataka, India. drknvraju@hotmail.com.
Abstract:
Biotin Thiamine responsive Basal Ganglia Disease (BTBGD) is a rare treatable autosomal recessive metabolic disorder caused by mutations in SLC19A3 gene. It usually presents with encephalopathy and dystonia; if not treated, can progress to quadriparesis and death. Two Indian siblings born to a consanguineous marriage presented with regression of milestones, epilepsy and dystonia. Neuroimaging showed signal changes in basal ganglia and thalami. Genetic testing showed a homozygous missense substitution p.Gly23Val (c.68G > T) in exon 2 of the SLC19A3 gene. Thus to conclude, any child who presents with neuroregression, epilepsy and dystonia in the background of basal ganglia changes on neuroimaging, a possibility of biotin thiamine responsive basal ganglia disease should be considered.
Related Concept Videos
Pedigree Analysis
Probability Laws
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inborn Errors of Metabolism
Lysosomal Hydrolases
Animal Mitochondrial Genetics

